Takeda

Business

Japan’s Takeda is buying Ariad Pharma for $5.2bn — Is this deal a bellwether for the biotech industry in 2017?

Given the scarcity of commercially-ready oncology assets, cancer drugs are appealing to big pharma with lots of cash and high…